Live Breaking News & Updates on சமிக்ஞை ஜெநெடிக்ஸ்
Stay updated with breaking news from சமிக்ஞை ஜெநெடிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kintara Therapeutics Appoints Tamara A. Seymour to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, May 4, 2021 SAN DIEGO, May 4, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the appointment of Tamara A. Seymour to the Company s Board of Directors replacing John Liatos, who will continue in his role as Kintara s Senior Vice President of Business Development. We are delighted to welcome Tamara to the Board of Directors as she brings exceptional healthcare sector experience as an accomplished financial and operational executive, commented Saiid Zarrabian, Kintara s President and Chief Executive Officer. Tamara s insights and perspectives will be a valuable addition to the Board and the entire Company as we continue to advance our platform assets VAL-083 and REM-001. We wish to thank John for his service to the Board and are excited to continue working with him as the Company s Senior VP of Business Develop ....
RNAi Want a sneak peek into the Oligonucleotide Therapeutics market? Access the “Table of Content” of Oligonucleotide Therapeutics market report! https://www.persistencemarketresearch.com/toc/12787 Oligonucleotide Therapeutics Market: Region-wise Outlook The presence of the main market leaders, market consolidation and commercialization of new molecules are all contributing towards the dominating position of North America in the oligonucleotides therapeutic market. Miragen Therapeutics, Inc. agreed to merge with Signal Genetics, Inc for an initial investment of USD 40 million. Through this merger both the companies expect to develop micro RNA-targeted oligonucleotide clinical products. New molecule application is also another strategy the market players are using to mark their presence in the oligonucleotide therapeutic market. Biogen recently received FDA approval for a new drug application for nusinersen. If approved, the antisense oligonucleotides molecule wo ....
Global Tissue Diagnostics Market 2020: Size, Share, Demand, Trends, Growth and 2026 Forecasts sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.